An open label, prospective, non-comparative, multicentre study to assess the safety and efficacy of Etanercept for injection 25 mg in patients with moderate to severe active rheumatoid arthritis.

Trial Profile

An open label, prospective, non-comparative, multicentre study to assess the safety and efficacy of Etanercept for injection 25 mg in patients with moderate to severe active rheumatoid arthritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Mar 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
    • 24 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
    • 08 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top